Blood Samples Could Be Used To Find Cancer-Specific Proteins Needed For Immunotherapy

(MENAFN- Investor Brand Network) Immunotherapy, a form of personalized cancer treatment, currently requires a tumor sample to be removed surgically and analyzed so that the personalized treatment needed by the patient can be manufactured. However, getting the needed tumor sample can be challenging in many patients, such as those with tumors in hard-to-access parts of the body or those whose physical condition makes it risky to have surgery done to extract a sample.

If additional clinical trials confirm the efficacy of the blood-based approach to obtaining data on cancer neoantigens and specific T-cell activation, the method could potentially reduce the time that is required to manufacture immunotherapies developed by entities like Calidi Biotherapeutics Inc. (NYSE American: CLDI)...

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

MENAFN02102026000224011066ID1111753431